Genesee Capital Advisors’s Axogen AXGN Stock Holding History

Genesee Capital Advisors’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-112,867	Closed	-$2.29M	–	52
2021 Q1	$2.29M	Sell	112,867 -35,679	-24%	-$705K	1.36%	20
2020 Q4	$2.66M	Sell	148,546 -367	-0.2%	-$5.39K	1.74%	19
2020 Q3	$1.73M	Buy	+148,913	New	+$1.73M	1.43%	23

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Genesee Capital Advisors's AXGN Position: Q2 2021 in Review

Genesee Capital Advisors sold out of Axogen (AXGN) in Q2 2021, closing a stake of 112,867 shares — an estimated $2.29M sold.

Genesee Capital Advisors first reported a position in AXGN in Q3 2020 and held it in 3 quarters. The position peaked at $2.66M in Q4 2020. 128 funds tracked by Wall St. Rank hold AXGN as of Q2 2021.

Genesee Capital Advisors reported no remaining Axogen position as of Q2 2021 after selling out during the quarter.
Genesee Capital Advisors sold 112,867 Axogen shares in Q2 2021, an estimated $2.29M.
Genesee Capital Advisors first reported a position in Axogen in Q3 2020 and held it in 3 quarters.
Genesee Capital Advisors's Axogen position peaked at $2.66M in Q4 2020.
128 funds tracked by Wall St. Rank held Axogen as of Q2 2021.

Based on Genesee Capital Advisors's 13F filing for Q2 2021, filed 20 Jul 2021.